Brand
name: CONUGASE
(Conjugated Estrogen, CONUGASE (Conjugated Estrogen, Premarin) rx)
Generic name: Conjugated estrogens
Other brand names: Cenestin, Premphase, Prempro
Why is CONUGASE (Conjugated Estrogen, Premarin) rx prescribed?
CONUGASE (Conjugated Estrogen, Premarin) rx is an estrogen replacement drug. The tablets are used to
reduce moderate to severe symptoms of menopause, including feelings
of warmth in the face, neck, and chest, and the sudden intense episodes
of heat and sweating known as "hot flashes." Cenestin tablets,
containing a synthetic form of conjugated estrogens, may also be prescribed
for these symptoms.
In addition to the symptoms of menopause, CONUGASE (Conjugated Estrogen, Premarin) rx tablets are prescribed
for teenagers who fail to mature at the usual rate, and to relieve
the symptoms of certain types of cancer, including some forms of breast
and prostate cancer.
In addition, either the tablets or CONUGASE (Conjugated Estrogen, Premarin) rx vaginal cream can be used
for other conditions caused by lack of estrogen, such as dry, itchy
external genitals and vaginal irritation.
Along with diet, calcium supplements, and exercise, CONUGASE (Conjugated Estrogen, Premarin) rx tablets
are also prescribed to prevent postmenopausal osteoporosis, a condition
in which the bones become brittle and easily broken. Before taking
CONUGASE (Conjugated Estrogen, Premarin) rx solely for this purpose, you should carefully consider using
alternative, nonestrogen therapies.
The addition of progesterone to estrogen-replacement therapy has been
shown to reduce the risk of uterine cancer. Prempro combines estrogen
and progesterone in a single tablet taken once daily. Premphase is
a 28-day supply of tablets. The first 14 contain only estrogen. The
second 14 supply both estrogen and progesterone. Both Prempro and Premphase
are prescribed to reduce the symptoms of menopause, including vaginal
problems, and to prevent osteoporosis.
Most important fact about CONUGASE (Conjugated Estrogen, Premarin) rx without prescriptions
Because estrogens have been linked with an increased risk of uterine
and endometrial ca
